Watch live: The Promise of Early Intervention — The ASAP Act and A New Look at Life with Alzheimer’s
Today, more than 7 million Americans are living with Alzheimer’s disease — a number projected to reach more than 13 million by 2050. Each year, more Americans lose their lives to Alzheimer’s than to breast cancer and prostate cancer combined, and women bear a disproportionate share of that burden. The condition is often associated with…
Today, more than 7 million Americans are living with Alzheimer’s disease — a number projected to reach more than 13 million by 2050.
Each year, more Americans lose their lives to Alzheimer’s than to breast cancer and prostate cancer combined, and women bear a disproportionate share of that burden.
The condition is often associated with late-stage decline, but many people diagnosed early continue to live full lives. Although FDA-approved blood tests exist, a recent survey conducted by HealthyWomen found that only 13 percent of women ages 45-64 are aware of them — despite 90 percent expressing interest in taking one.
Awareness is not the only barrier to access: Medicare is not authorized to cover blood tests cleared for Alzheimer’s screening. To bridge this gap, bipartisan lawmakers have introduced the Alzheimer’s Screening and Prevention Act (ASAP), which would make blood screening tests available under the federal insurance program.
Join The Hill, in partnership with HealthyWomen, for a policy briefing featuring lawmakers, health experts, patients and advocates as we discuss the survey and expanding access to early Alzheimer’s testing.
The event features This is ALZ, a HealthyWomen campaign highlighting the real experiences of people living with the earlier stages of the condition.
The event is scheduled to begin at 12:30 p.m. EST.
Topics in this story
Gathered from external sources. Rights to this text belong to whoever originally published it.